COVID_Vaccines_June_Emblem
Meeting category
Date(s)
14 Dec 2022 - 15 Dec 2022
Program Language
English
Meeting type
Webinar & Virtual Meeting
EACCME Credits
5
Organizer

International Workshop on COVID-19 Vaccines 2022 - December Edition

Related Enduring Materials

Enduring Materials

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

Pre-Workshop Webinar - Global Consensus Webinar -
A Mask Is Not a Mask - Why Some Facemasks Are Better Than Others
Jose-Luis Jimenez, PhD
University of Colorado, United States​
Vaccine Hesitancy
Scott C. Ratzan MD, MPA, MA
CUNY Graduate School of Public Health and Health Policy, Columbia University Mailman School of Public Health, Tufts University School of Medicine, United States; University of St Andrews, Scotland
Immunity Due to the Previous Infection
Carlos del Rio, MD
Emory School of Medicine & Grady Health System, United States
Day 1 -
Session 1: State of the Art
Current Status of the Most Dominant SARS-CoV2 Variant
Penny Moore, PhD
University of the Witwatersrand / National Institute for Communicable Diseases, South Africa
Newly Approved and Rolled Out Vaccines
Kathleen Neuzil, MD
University of Maryland School of Medicine, United States
Immunogenicity of the New and Modified Boosters
Angela Branche, MD
University of Rochester, United States
Session 2: Vaccine Protection
Vaccine Protection within the School Setting
Westyn Branch-Elliman, MD, MMSc
Harvard Medical School, United States
The Role of Bivalent Boosters
Nadine Rouphael, MD, MSc, FSSCI, FIDSA
Emory University, United States
Affinity Maturation and Immune Imprinting - Implications for Vaccine Schedule
Gabriel Victora, PhD
Laboratory of Lymphocyte Dynamics, Rockefeller University, United States
Panel Discussion on Regional perspectives of COVID-19 Vaccines
Perspectives from Africa
François Venter, MD, FCP, PhD
Ezintsha, University of the Witwatersrand, South Africa
Perspectives from CEE
Miłosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
Perspectives from Latin America
Beatriz Grinsztejn, MD, PhD
Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Brazil
Mini Oral Poster Session
Day 2 -
Session 3: Vaccine Safety
Pediatric Vaccinations
C. Buddy Creech, MD, MPH, FPIDS
Vanderbilt University School of Medicine and Medical Center, United States
Vaccine-Related Adverse Events / Long-Term Data
John R. Su, MD, PhD, MPH
Centers for Disease Control and Prevention, United States
Session 4: Abstract-driven session - Community Response
Knowledge, attitudes and practises towards COVID-19 vaccination among pregnant and lactating women in TASQC-supported districts of Zimbabwe; a descriptive cross-sectional study, August-September 2022
Evaluation of Conspiracy beliefs, Vaccine hesitancy and Willingness to pay towards COVID-19 vaccines in Six Countries from Asian and African regions; A Large Multinational Analysis
From Ports to Arms: Reimagining Demand Creation for the African Context
Session 5: Public Health policies
Vaccination Requirements - Countries & Company Policies
Michel Kazatchkine, MD
The Global Health Center, Graduate Institute for International Affairs and Development, Switzerland
Masks and Other Non-Pharmaceutical Interventions- Is It Time to Return to Our Pre-Pandemic Ways?
Shira Doron, MD, FIDSA
Tufts Medical Center, Tufts University School of Medicine, United States
Pros and Cons of Global Roll-Out
Oliver Watson, PhD
Imperial College London, United Kingdom
Overview
What's New | 2023 Editions

The Organizing Committee of this workshop is monitoring the pandemic closely.

Further editions of this workshop will be determined based on global developments.

For frequent updates on COVID-19, we invite you to attend our COVID Clinical Forums 

Welcome

The International Workshop on COVID-19 Vaccines virtual event took place on 14-15 December 2022.

This workshop was designed to increase knowledge and facilitate discussion on the many aspects of vaccine development and implementation programs on a background of a firm understanding of pathogenesis and natural infection.

Our goal was to address the many scientific, social, and policy challenges in the totality of delivering an effective COVID-19 vaccine.

This global program aimed at increasing the competence of healthcare professionals (HCP) on the clinical relevance of the COVID-19 vaccine, with a focus on different patient populations (high comorbid burden, different ages, etc.).

This was done in the truly global context of the COVID-19 pandemic, considering regional differences in access to medications, health system capacity, and public measures.

The first three editions of this workshop were exceptionally successful in gathering experts and discussing the many aspects of vaccine development and rollout in 2021 and 2022.

Program Directors
Global Consensus Webinar

Global COVID-19 Consensus Webinar

Published in Nature on 3 November, the multinational Delphi consensus to end the COVID-19 public health threat has taken the infectious disease community by storm!

Featuring the input of 386 experts from 112 countries, this paper provides actionable insights across 41 statements and 57 recommendations in six major areas:

Communication | Health systems | Vaccination| Prevention | Treatment and care | Inequities

We were very proud to present the COVID-19 Consensus Webinar on vaccine hesitancy and other key issues.

This webinar, featuring the lead author on the consensus statement, Dr. Jeffrey Lazarus, was held as a pre-webinar ahead of the COVID-19 Vaccine Workshop.

Free for industry and healthcare professionals – this 45-minute program addressed not only the statement, but also the implementation aspects.

General Information 
Who Should Attend?
- Virologists, immunologists, and scientists involved or interested in vaccine research and physicians caring for COVID-19 patients;
- Nurses, and other healthcare professionals involved in the care of COVID-19; patients, policymakers, and (non)government representatives; and
- Healthcare administrators.
Meeting Objectives
The workshop aimed to:
- Create a platform for scientific exchange and discussion around COVID-19 vaccines;
- Outline challenges related to COVID-19 vaccination policies and hesitancy;
- Provide a platform to discuss regional aspects of COVID-19 vaccines.
Learning Objectives
On the completion of the proposed activity participants are now able to:
- Describe current vaccines in use, their safety, effectiveness, and dosing
- Define which vaccines are being developed
- Outline the global vaccine epidemiology
- Define the scheduling and recommend who to prioritize for vaccinations and booster
doses
- Discuss policies, equal roll-out, and vaccine hesitancy
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Language
The official language of the workshop was English
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Organizing Committee
Support

The International Workshop on COVID-19 Vaccines 2022 - December Edition is supported by an independent education grant from Pfizer Inc.

Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers involved in COVID-19.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Mrs. Tara de Beer at tara.debeer@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Non-commercial interviews with company representatives
  • Verbal acknowledgement during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgement on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level.

Endorsers
The International Workshop on COVID-19 Vaccines 2022 was endorsed by the following organizations: